HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

WST

West Pharmaceutical Services, Inc. (S&P 500)

Healthcare — Medical Instruments & Supplies

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Strong Buy 1.4 / 5 16 analysts
$365.01
$-5.75 (-1.55%)
Target: $407.56 (11.7%)

Price History

52-Week Range
Sign in to add WST to a watchlist or set price alerts.

Fundamentals

Market Cap$25.69B
P/E Ratio (TTM)46.68
Forward P/E36.56
EPS (TTM)$7.82
Dividend Yield0.24%
Profit Margin16.98%
Revenue Growth13.80%
ROE19.09%
Debt/Equity10.59
Recommendation Strong Buy 1.4
Analyst Target$407.56
Analysts16
Next Earnings Jul 23, 2026 BMO
Indexes S&P 500

Technical Indicators

RSI (14)63.7
Beta1.14
SMA 20$359.99
SMA 40$354.11
52-Week High$386.00
52-Week Low$223.83
50-Day Avg$351.51
200-Day Avg$301.37
Avg Volume640.9K
Volume639.0K

Performance Analysis

BULLISH

WST shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 87% of its 52-week range.
+ RSI at 63.7 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 46.7 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 13.8% year-over-year.
+ Wall Street consensus is "Strong Buy" from 16 analysts.
+ Average analyst target of $407.56 implies 11.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:01 UTC

Back to Screener Export Report